HIGH-GRADE TA/ T1 PAPILLARY DISEASE BLADDER CANCER

Clinical trials for HIGH-GRADE TA/ T1 PAPILLARY DISEASE BLADDER CANCER explained in plain language.

Never miss a new study

Get alerted when new HIGH-GRADE TA/ T1 PAPILLARY DISEASE BLADDER CANCER trials appear

Sign up with your email to follow new studies for HIGH-GRADE TA/ T1 PAPILLARY DISEASE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Virus therapy targets tough bladder cancer after standard treatment fails

Disease control Recruiting now

This study is testing a new treatment called cretostimogene grenadenorepvec for people with high-risk bladder cancer that hasn't responded to standard BCG therapy. The treatment involves putting a modified virus directly into the bladder to try to kill cancer cells. Researchers w…

Matched conditions: HIGH-GRADE TA/ T1 PAPILLARY DISEASE BLADDER CANCER

Phase: PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control

Last updated Apr 02, 2026 02:41 UTC

HIGH-GRADE TA/ T1 PAPILLARY DISEASE BLADDER CANCER

Get alerted when new HIGH-GRADE TA/ T1 PAPILLARY DISEASE BLADDER CANCER trials appear

Virus therapy targets tough bladder cancer after standard treatment fails